Home » GUIDANT EXEC SAYS TOLD FDA DEFIBRILLATOR CHANGE HAD NO EFFECT
GUIDANT EXEC SAYS TOLD FDA DEFIBRILLATOR CHANGE HAD NO EFFECT
A Guidant Corp. (GDT) executive acknowledged the medical-device maker made changes to one of its defibrillators in 2002 and later incorrectly told federal regulators it had no effect on the product's performance.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May